Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-031011

Chief Financial Officer acquired 95,889 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gabay Avraham Chief Financial Officer 2026-03-17 Grant or award +95,889 745,145 D: show line 1 in the form
Loading xslF345X06/ownership.xml…